Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 207533

Expand all

ARISTADA (ARIPIPRAZOLE LAUROXIL)
441MG/1.6ML (275.63MG/ML) Marketing Status: Prescription

Active Ingredient: ARIPIPRAZOLE LAUROXIL
Proprietary Name: ARISTADA
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 441MG/1.6ML (275.63MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207533
Product Number: 001
Approval Date: Oct 5, 2015
Applicant Holder Full Name: ALKERMES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ARISTADA (ARIPIPRAZOLE LAUROXIL)
662MG/2.4ML (275.83MG/ML) Marketing Status: Prescription

Active Ingredient: ARIPIPRAZOLE LAUROXIL
Proprietary Name: ARISTADA
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 662MG/2.4ML (275.83MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207533
Product Number: 002
Approval Date: Oct 5, 2015
Applicant Holder Full Name: ALKERMES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ARISTADA (ARIPIPRAZOLE LAUROXIL)
882MG/3.2ML (275.63MG/ML) Marketing Status: Prescription

Active Ingredient: ARIPIPRAZOLE LAUROXIL
Proprietary Name: ARISTADA
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 882MG/3.2ML (275.63MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N207533
Product Number: 003
Approval Date: Oct 5, 2015
Applicant Holder Full Name: ALKERMES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ARISTADA (ARIPIPRAZOLE LAUROXIL)
1064MG/3.9ML (272.82MG/ML) Marketing Status: Prescription

Active Ingredient: ARIPIPRAZOLE LAUROXIL
Proprietary Name: ARISTADA
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR
Strength: 1064MG/3.9ML (272.82MG/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N207533
Product Number: 004
Approval Date: Jun 5, 2017
Applicant Holder Full Name: ALKERMES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English